1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Orally Inhaled Corticosteroids to 2022

Orally Inhaled Corticosteroids to 2022

  • April 2015
  • -
  • Greystone Research Associates

Asthma continues to be a health segment that presents challenges to the caregiver community. Patient adherence with prescribing instructions and treatment protocols remains sub-optimal across all patient categories, but particularly for the young and the elderly. This has led to significant interest on the part of device and combination product providers directed toward the development easier-to-use inhalers. Because they reduce inflammation and swelling in the airways, orally inhaled corticosteroids are an indispensable tool for the treatment of asthma. The market entry of combination drug inhalers that deliver a corticosteroid and a bronchodilator from the same inhaler are providing important options for both clinicians and patients.

Highlights

• Analyzes the market for corticosteroid drugs delivered via oral inhalers
• Assesses inhalation device technology for delivering corticosteroids orally, and evaluates product technology issues and evolving market factors
• Provides detailed assessments of orally inhaled corticosteroid product segments, growth prospects and market potential
• Provides market data and forecasts for orally inhaled corticosteroid drugs to 2022
• Profiles inhaled drug product market participants, their technology, product development activity, and business strategies
• Evaluates the impact of economic, technology, and regulatory factors on inhaled drug companies and their alliance partners

Table Of Contents

Orally Inhaled Corticosteroids to 2022
Executive Summary

Orally Inhaled Corticosteroid Market Overview

The Asthma Therapeutics Marketspace
Competing Drug Treatments
Corticosteroids and Asthma
Demand Drivers
Technology Factors
Competitive Landscape

Asthma Market Risks and Opportunities

Global Patient Demographics
Regional Market Drivers
Pediatric Asthma -the Growing Therapeutic Need

Inhaler Technologies for Delivering Corticosteroids

Dry Powder Inhalers
DPI Formulation Technology
Characteristics and Parameters
DPI Excipients and Packaging
Metered Dose Inhalers
MDI Device Selection Criteria
Ease-of-Use Factors
Nebulizers

Inhaled Corticosteroids - Product Analysis, Market Data and Forecasts

Beclomethasone, QVAR 40/80 (MDI)
Budesonide, Pulmicort (DPI)
Budesonide, Pulmicort (Nebulizer)
Generic Budesonide (Nebulizer)
Budesonide/Formoterol (Symbicort) Combination Drug Inhaler (MDI)
Ciclesonide, Alvesco (MDI)
Ciclesonide, Zetonna (MDI)
Flunisolide, Aerospan HFA (MDI)
Fluticasone, Arnuity Ellipta (DPI)
Fluticasone, Flovent HFA (MDI)
Fluticasone, Flovent Diskus50/100/250 (DPI)
Fluticasone/Salmeterol (Advair HFA) Combination Drug Inhaler (MDI)
Fluticasone/Salmeterol (Advair Diskus) Combination Drug Inhaler (DPI)
Fluticasone/Vilanterol (Breo Ellipta) Combination Drug Inhaler (DPI)
Mometasone, Asmanex HFA (MDI)
Mometasone, Asmanex Twisthaler (DPI)
Umeclidinium, Incruse Ellipta (DPI)
Umeclidinium/Vilanterol (Anora Ellipta) Combination Drug Inhaler (DPI)

Market Factors

Regulatory Issues
Patient Compliance
Prescribing Trends
Healthcare Economics
Regional Market Factors
Connected Devices

Market Sector Company Profiles

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Europe Tumor Marker Testing in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppl

2016 Europe Tumor Marker Testing in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppl

  • $ 34500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 28-country survey from VPGMarketResearch.com contains over 925 pages and 366 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.